Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
出版年份 2019 全文链接
标题
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 18, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-04-27
DOI
10.1186/s12933-019-0860-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
- (2018) Cheng-Wei Chan et al. Cardiovascular Diabetology
- Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes
- (2018) Xiao-min Chen et al. Cardiovascular Diabetology
- The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
- (2018) Fiona J. Dore et al. Cardiovascular Diabetology
- Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
- (2018) Emelia J. Benjamin et al. CIRCULATION
- Metformin ameliorates the progression of atherosclerosis via suppressing macrophage infiltration and inflammatory responses in rabbits
- (2018) Qiangbing Yang et al. LIFE SCIENCES
- Metformin Is Associated with Improved Survival and Decreased Cardiac Events with No Impact on Patency and Limb Salvage after Revascularization for Peripheral Arterial Disease
- (2018) Sikandar Z. Khan et al. ANNALS OF VASCULAR SURGERY
- Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
- (2018) Mojca Lunder et al. Cardiovascular Diabetology
- Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)
- (2018) Mikhail Kosiborod et al. Cardiovascular Diabetology
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance
- (2018) Rebecca E. Slater et al. JOURNAL OF GENERAL PHYSIOLOGY
- Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease
- (2018) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease
- (2018) Julia C. Wilmanns et al. Molecular Metabolism
- Hypertriglyceridemia and atherosclerosis
- (2017) Jia Peng et al. Lipids in Health and Disease
- Estrogen lowers triglyceride via regulating hepatic APOA5 expression
- (2017) Fei Luo et al. Lipids in Health and Disease
- Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet
- (2017) Fei Luo et al. Scientific Reports
- Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
- (2017) John R Petrie et al. Lancet Diabetes & Endocrinology
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway
- (2016) Rong Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque StabilityNovelty and Significance
- (2016) Ye Ding et al. CIRCULATION RESEARCH
- Ablation of Adenosine Monophosphate-Activated Protein Kinase α1 in Vascular Smooth Muscle Cells Promotes Diet-Induced Atherosclerotic Calcification In VivoNovelty and Significance
- (2016) Zhejun Cai et al. CIRCULATION RESEARCH
- Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
- (2016) Fei Luo et al. Lipids in Health and Disease
- Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program
- (2016) Ronald B. Goldberg et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
- (2015) Tao Xu et al. DIABETES CARE
- Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
- (2015) Shona J. Livingstone et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dysfunctional HDL and atherosclerotic cardiovascular disease
- (2015) Robert S. Rosenson et al. Nature Reviews Cardiology
- Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
- (2015) Sathish Babu Vasamsetti et al. DIABETES
- Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients
- (2014) Gian Paolo Fadini et al. ATHEROSCLEROSIS
- Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis
- (2014) Linnéa Eriksson et al. Cardiovascular Diabetology
- Mechanisms of Plaque Formation and Rupture
- (2014) Jacob Fog Bentzon et al. CIRCULATION RESEARCH
- Relationship between Serum Cholesterol Efflux Capacity and Glucose Intolerance in Japanese-Americans
- (2014) Mitsunobu Kubota et al. Journal of Atherosclerosis and Thrombosis
- Metformin Suppresses Lipopolysaccharide (LPS)-induced Inflammatory Response in Murine Macrophages via Activating Transcription Factor-3 (ATF-3) Induction
- (2014) Juyoung Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
- (2014) Anand Rohatgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
- (2014) Farshad Forouzandeh et al. Journal of the American Heart Association
- Adenosine Monophosphate–Activated Protein Kinase-α2 Deficiency Promotes Vascular Smooth Muscle Cell Migration via S-Phase Kinase–Associated Protein 2 Upregulation and E-Cadherin Downregulation
- (2013) Ping Song et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inflammation and immune system interactions in atherosclerosis
- (2013) Bart Legein et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Foam cells in atherosclerosis
- (2013) Xiao-Hua Yu et al. CLINICA CHIMICA ACTA
- Metformin Lowers Plasma Triglycerides by Promoting VLDL-Triglyceride Clearance by Brown Adipose Tissue in Mice
- (2013) J. J. Geerling et al. DIABETES
- Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
- (2013) David Preiss et al. Lancet Diabetes & Endocrinology
- Impact of Diabetes on Cardiovascular Disease: An Update
- (2013) Alessandra Saldanha de Mattos Matheus et al. International Journal of Hypertension
- Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2012) J. Hong et al. DIABETES CARE
- Macrophages in the Pathogenesis of Atherosclerosis
- (2011) Kathryn J. Moore et al. CELL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Metformin Causes Nitric Oxide–mediated Dilatation in a Shorter Time Than Insulin in the Iliac Artery of the Anesthetized Pig
- (2011) Theres Ruane OʼHora et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Reduction of AMP-Activated Protein Kinase α2 Increases Endoplasmic Reticulum Stress and Atherosclerosis In Vivo
- (2010) Yunzhou Dong et al. CIRCULATION
- Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
- (2010) C. Lamanna et al. DIABETES OBESITY & METABOLISM
- Adenosine Monophosphate-activated Protein Kinase Induces Cholesterol Efflux from Macrophage-derived Foam Cells and Alleviates Atherosclerosis in Apolipoprotein E-deficient Mice
- (2010) Dan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
- (2009) Adriaan Kooy et al. ARCHIVES OF INTERNAL MEDICINE
- Metformin restores impaired HDL-mediated cholesterol efflux due to glycation
- (2009) Kota Matsuki et al. ATHEROSCLEROSIS
- Metformin inhibits nuclear factor κB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits
- (2009) Song-Nan Li et al. HEART AND VESSELS
- METFORMIN, ARTERIAL FUNCTION, INTIMAMEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY
- (2008) Eduardo Meaney et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- (2008) Mojca Jensterle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started